NMD4C Launch Canadian Neuromuscular Clinical Trial Database

The NMD4C are excited to launch the The Canadian Neuromuscular Clinical Trial Database to provide a comprehensive and reliable landscape of Canadian neuromuscular clinical trials. The trial database is an initiative of the NMD4C Clinical Trial Network (CTN) created in collaboration with Canadian neuromuscular clinical trial site teams. Monthly updates are provided by clinical research coordinators working at Canadian trial sites, ensuring the most current information is always available.

View the database here!

The Canadian Neuromuscular Clinical Trial Database has been designed to meet the needs of Canadian neuromuscular trial community stakeholders.

  • Providing accurate and up-to-date information: Our database provides reliable details about recruiting and not yet recruiting neuromuscular clinical trials, including clinical trial site locations and contact information.
  • Fostering collaboration: Enables investigators to identify other sites conducting the same trial at different locations, fostering collaboration to address challenges and share best practices,
  • Streamlining patient referral: Can be used as a tool to facilitate patient referral to appropriate clinical trials and/or clinical sites.

The database will continue to be updated and expanded. If you have any questions about the Canadian Neuromuscular Clinical Trial Database or would like to add your site to our list, please contact CTN manager Dr. Maria Masnata.

The NMD4C CTN is led by Dr. Craig Campbell, Dr. Jean Mah, and Dr. Kerri Schellenberg, with the objectives of increasing the number of clinical trials in Canada, enhance Canadian sites’ trial capacity, and support a cohesive network of clinician researchers and their teams.

Canadian Neuromuscular Clinical Trial Database

Read next...

CIHR logo

Emerging Leaders Webinar and Workshop Series from the CIHR-Institute of Musculoskeletal Health and Arthritis

The Emerging Leaders Series at CIHR-IMHA is designed to support learning and career development for a new generation of equitable and inclusive leaders in health research.

NMD4C launches 2024-2025 NNLS

NMD4C Launch Third Annual Training Series for Clinical Neuromuscular Fellows

The NMD4C Clinical Research Curriculum Development team is pleased to share that the third annual National Neuromuscular Lecture Series began this past August.

2025 clinical and research fellowships competition from NMD4C and MDC.

2025 NMD4C and MDC Neuromuscular Fellowship Funding Competition Opens

Together with MDC we are excited to announce the opening of our 2025 annual funding competition to award postdoctoral fellowships in NMD research, and clinical fellowship awards in neuromuscular medicine and electromyography! 

MDC-researchgrants-2025

MDC Translational Science and Clinical Research Grants Competition Opens for 2024-25

Muscular Dystrophy Canada’s annual Neuromuscular Research Grant Program invests in
projects related to the diagnosis, treatment, or clinical care of neuromuscular disorders.

RareKids-CAN logo

RareKids-CAN Offer Subsidized Services for Investigator-initiated Academic Clinical Trials

RareKids-CAN offers a range of subsidized services for investigator-initiated (academic-led) pediatric rare disease clinical trials.

Canada-reaches-100NBS_900px

100 percent of Canada is Now Screening Infants for Spinal Muscular Atrophy

We are excited to share that from August 20, 2024, all babies born in Canada can now be tested for spinal muscular atrophy (SMA), a potentially fatal neuromuscular disorder.